Lupin Expands Europe Access to YUVEZZI Presbyopia Therapy
Mumbai, India; Amsterdam, Netherlands; London, UK; Naples, Florida; Warren, New Jersey, August 20, 2026 Lupin Limited and Tenpoint Therapeutics...
foundation models
Advertisement
HealthTab and Abbott Expand UK Point-of-Care Testing
Vancouver, British Columbia, August 20, 2026 Avricore Health Inc. has announced that its wholly owned subsidiary, HealthTab Ltd., has...
FDA Seeks Input on Generative AI Medical Device Rules
Silver Spring, Maryland, August 18, 2026 The U.S. Food and Drug Administration (FDA) has issued a new discussion paper...
Apertura Reports Progress in AAV Gene Therapy for TSC1
SILVER SPRING, Md. and NEW YORK, July 30, 2026 The TSC Alliance and Apertura Gene Therapy have announced the...
Relation and GSK Expand $110M AI Drug Discovery Alliance
LONDON, July 30, 2026 Relation Therapeutics has announced an expanded strategic collaboration with GSK that will accelerate the use...
Advertisements
Bristol Myers Squibb Expands AI Collaboration with NVIDIA
PRINCETON, N.J., July 20, 2026 Bristol Myers Squibb (BMS) announced a major expansion of its strategic collaboration with NVIDIA...
Alnylam and Inceptive Forge $2B AI-RNAi Discovery Alliance
CAMBRIDGE, Massachusetts, USA & PALO ALTO, California, USA, June 3, 2026 Alnylam Pharmaceuticals and Inceptive Nucleics have announced a...
Human Longevity and Insilico Launch AI Longevity Platform
SOUTH SAN FRANCISCO, California, May 27, 2026 Human Longevity, Inc. (HLI) has announced the creation of Human Life Foundation...
Liquid AI, Insilico Launch AI Models for Drug Discovery
March 08, 2026 — Cambridge, MA, USA The rapid integration of artificial intelligence in pharmaceutical research continues to reshape...
GSK Partners With Noetik to Transform AI-Driven Cancer R&D
SAN FRANCISCO | January 9, 2026 — GSK has entered into a five-year strategic collaboration and AI model licensing...
Advertisement
